Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) Target Price at $16.25

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been given an average recommendation of “Hold” by the six brokerages that are currently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $17.08.

Several equities analysts have issued reports on MD shares. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Macquarie started coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective for the company. Truist Financial upped their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday. Jefferies Financial Group boosted their price objective on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Finally, Mizuho increased their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Tuesday, November 19th.

Institutional Trading of Pediatrix Medical Group

Institutional investors and hedge funds have recently modified their holdings of the business. Quest Partners LLC increased its holdings in shares of Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares during the period. Everence Capital Management Inc. grew its position in Pediatrix Medical Group by 7.5% in the 4th quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock worth $182,000 after purchasing an additional 960 shares during the last quarter. Parkside Financial Bank & Trust increased its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after purchasing an additional 1,040 shares during the period. Nomura Asset Management Co. Ltd. raised its holdings in shares of Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock valued at $33,000 after buying an additional 1,220 shares during the last quarter. Finally, Quarry LP boosted its position in shares of Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after buying an additional 1,662 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Trading Down 9.6 %

Shares of Pediatrix Medical Group stock opened at $15.57 on Wednesday. The company has a fifty day simple moving average of $13.89 and a 200-day simple moving average of $13.01. Pediatrix Medical Group has a 12-month low of $6.62 and a 12-month high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The stock has a market cap of $1.34 billion, a price-to-earnings ratio of -12.97, a PEG ratio of 1.74 and a beta of 1.57.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, equities analysts forecast that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.